Laura Valsecchi
Milan, 20157, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Incident diabetes in course of antiretroviral therapy.
Journal: AIDS (London, England)
Published: March 17, 2023
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir.
Journal: PloS one
Published: February 01, 2023
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study.
Journal: Viruses
Published: January 23, 2023
Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort.
Journal: Frontiers in medicine
Published: October 31, 2022
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
Journal: BMC infectious diseases
Published: April 07, 2022
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study.
Journal: AIDS patient care and STDs
Published: September 15, 2021
Factors associated with hospital admission for COVID-19 in HIV patients.
Journal: AIDS (London, England)
Published: August 16, 2020
Factors Associated With Weight Gain in People Treated With Dolutegravir.
Journal: Open forum infectious diseases
Published: March 16, 2020
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA).
Journal: AIDS research and therapy
Published: June 06, 2019
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.
Journal: Infection and drug resistance
Published: May 08, 2018
Last Updated: 09/26/2026